Bright Rock Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bright Rock Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69M	Hold	7,000	–	–	0.74%	45
2026 Q1	$3.93M	Hold	7,000	–	–	0.78%	46
2025 Q4	$4.74M	Hold	7,000	–	–	0.93%	40
2025 Q3	$4.47M	Hold	7,000	–	–	0.88%	44
2025 Q2	$3.75M	Hold	7,000	–	–	0.76%	46
2025 Q1	$2.94M	Hold	7,000	–	–	0.62%	54
2024 Q4	$2.89M	Hold	7,000	–	–	0.62%	51
2024 Q3	$3.54M	Hold	7,000	–	–	0.71%	48
2024 Q2	$3.41M	Hold	7,000	–	–	0.72%	47
2024 Q1	$3.78M	Hold	7,000	–	–	0.78%	44
2023 Q4	$3.89M	Hold	7,000	–	–	0.88%	39
2023 Q3	$3.06M	Hold	7,000	–	–	0.75%	42
2023 Q2	$3.52M	Hold	7,000	–	–	0.82%	40
2023 Q1	$3.5M	Hold	7,000	–	–	0.88%	37
2022 Q4	$2.86M	Hold	7,000	–	–	0.74%	42
2022 Q3	$2.28M	Hold	7,000	–	–	0.64%	49
2022 Q2	$2.46M	Hold	7,000	–	–	0.66%	49
2022 Q1	$3.83M	Hold	7,000	–	–	0.9%	41
2021 Q4	$4.61M	Hold	7,000	–	–	1.05%	39
2021 Q3	$4.35M	Sell	7,000 -2,000	-22%	-$1.34M	1.09%	38
2021 Q2	$5.68M	Hold	9,000	–	–	1.37%	32
2021 Q1	$4.4M	Hold	9,000	–	–	1.13%	38
2020 Q4	$4.5M	Hold	9,000	–	–	1.23%	38
2020 Q3	$3.54M	Sell	9,000 -1,600	-15%	-$592K	1.05%	41
2020 Q2	$3.5M	Hold	10,600	–	–	1.09%	39
2020 Q1	$2.57M	Hold	10,600	–	–	0.94%	43
2019 Q4	$2.77M	Hold	10,600	–	–	0.81%	45
2019 Q3	$2.86M	Sell	10,600 -3,000	-22%	-$835K	0.9%	43
2019 Q2	$3.74M	Hold	13,600	–	–	1.2%	40
2019 Q1	$3.04M	Hold	13,600	–	–	1.02%	42
2018 Q4	$2.53M	Hold	13,600	–	–	0.95%	40
2018 Q3	$3.4M	Hold	13,600	–	–	1.11%	39
2018 Q2	$2.96M	Hold	13,600	–	–	1.02%	40
2018 Q1	$2.6M	Hold	13,600	–	–	0.89%	43
2017 Q4	$2.13M	Hold	13,600	–	–	0.58%	58
2017 Q3	$2.12M	Hold	13,600	–	–	0.61%	56
2017 Q2	$2.19M	Sell	13,600 -1,900	-12%	-$309K	0.65%	55
2017 Q1	$2.4M	Sell	15,500 -3,500	-18%	-$482K	0.72%	52
2016 Q4	$2.23M	Hold	19,000	–	–	0.69%	51
2016 Q3	$2.14M	Sell	19,000 -8,000	-30%	-$843K	0.68%	53
2016 Q2	$2.51M	Hold	27,000	–	–	0.81%	50
2016 Q1	$2.12M	Hold	27,000	–	–	0.72%	50
2015 Q4	$1.97M	Buy	27,000 +1,600	+6%	+$114K	0.73%	50
2015 Q3	$1.89M	Hold	25,400	–	–	0.76%	48
2015 Q2	$1.63M	Hold	25,400	–	–	0.61%	57
2015 Q1	$1.96M	Hold	25,400	–	–	0.73%	51
2014 Q4	$1.88M	Hold	25,400	–	–	0.74%	49
2014 Q3	$1.5M	Hold	25,400	–	–	0.64%	51
2014 Q2	$1.7M	Hold	25,400	–	–	0.8%	40
2014 Q1	$1.54M	Hold	25,400	–	–	0.78%	41
2013 Q4	$1.35M	Hold	25,400	–	–	0.71%	48
2013 Q3	$1.27M	Hold	25,400	–	–	0.71%	48
2013 Q2	$1.14M	Buy	+25,400	New	+$1.11M	0.7%	49

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bright Rock Capital Management's IDXX Position: Q2 2026 in Review

Bright Rock Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 7,000 shares worth $3.69M. The position accounts for 0.74% of the portfolio, ranked #45.

Bright Rock Capital Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.68M in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Bright Rock Capital Management held 7,000 shares of Idexx Laboratories worth $3.69M as of Q2 2026.
Bright Rock Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.74% of Bright Rock Capital Management's portfolio in Q2 2026, its #45 holding.
Bright Rock Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
Bright Rock Capital Management's Idexx Laboratories position peaked at $5.68M in Q2 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bright Rock Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.